Investigación / Grupos de investigación

Grupo  29

Farmacología y Fisiopatología Vascular

Publicaciones (97)

  • Barreira, B; Ricarte, JJ; Ros, L; Fernández-Pérez, D.

    Association between trait rumination and co-rumination in instant messaging and its possible relationship to depressive symptomatology

    PERSONALITY AND INDIVIDUAL DIFFERENCES. 2025; 244: [doi:10.1016/j.paid.2025.113259]

  • Olivencia, MA; Climent, B; Barreira, B; Morales-Cano, D; Sánchez, A; Fernández, A; García-Gómez, B; Romero-Otero, J; Rodríguez, C; Moreno, L; Prieto, D; Larriba, MJ; Cogolludo, A; Angulo, J; Perez-Vizcaino, F.

    Vitamin D deficiency induces erectile dysfunction: Role of superoxide and Slpi

    BRITISH JOURNAL OF PHARMACOLOGY. 2025; 182(15): 3669-3687 [doi:10.1111/bph.70034]

  • Adao, R; Barreira, B; Paternoster, E; Morales-Cano, D; Olivencia, MA; Quintana-Villamandos, B; Rodríguez-Chiaradía, DA; Cogolludo, A; Perez-Vizcaino, F.

    Vitamin D as an add-on therapy to phosphodiesterase-5 inhibitor in experimental pulmonary arterial hypertension

    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. 2025; 328(2): 253-259 [doi:10.1152/ajplung.00319.2024]

  • Assis, MQ; Leite, LB; Guimaraes-Ervilha, LO; Adao, R; Reis, ECC; Natali, AJ; Machado-Neves, M.

    Pulmonary Arterial Hypertension-Induced Reproductive Damage: Effects of Combined Physical Training on Testicular and Epididymal Parameters in Rats

    Biomedicines. 2025; 13(2): [doi:10.3390/biomedicines13020410]

  • Callejo, M; Morales-Cano, D; Olivencia, MA; Mondejar-Parreño, G; Barreira, B; Tura-Ceide, O; Martínez, VG; Serrano-Navarro, A; Moreno, L; Morrell, N; Perros, F; Vicente, A; Cogolludo, A; Perez-Vizcaino, F.

    Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension

    Scientific Reports. 2024; 14(1): Nº de citas: 3 [doi:10.1038/s41598-024-78380-9]

  • Santos-Gomes, J; Mendes-Ferreira, P; Adao, R; Maia-Rocha, C; Rego, B; Poels, M; Willer, AS; Masson, B; Provencher, S; Bonnet, S; Montani, D; Perros, F; Antigny, F; Leite-Moreira, AF; Brás-Silva, C.

    Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15): Nº de citas: 3 [doi:10.3390/ijms25158054]

  • Le Ribeuz, H; Willer, ASM; Chevalier, B; Sancho, M; Masson, B; Eyries, M; Jung, V; Guerrera, IC; Dutheil, M; El Jekmek, K; Laubry, L; Carpentier, G; Perez-Vizcaino, F; Tu, L; Guignabert, C; Chaumais, MC; Péchoux, C; Humbert, M; Hinzpeter, A; Mercier, O; Capuano, V; Montani, D; Antigny, F.

    Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction

    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 2024; 71(1): 95-109 Nº de citas: 3 [doi:10.1165/rcmb.2023-0185OC]

  • Morales-Cano, D; Barreira, B; Callejo, M; Olivencia, MA; Ferruelo, A; Milara, J; Lorente, JA; Moreno, L; Cogolludo, A; Perez-Vizcaino, F.

    Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human

    VASCULAR PHARMACOLOGY. 2024; 155: [doi:10.1016/j.vph.2024.107371]

  • Vera-Zambrano, A; Lago-Docampo, M; Gallego, N; Franco-Gonzalez, JF; Morales-Cano, D; Cruz-Utrilla, A; Villegas-Esguevillas, M; Fernandez-Malave, E; Escribano-Subias, P; Tenorio-Castano, JA; Perez-Vizcaino, F; Valverde, D; Gonzalez, T; Cogolludo, A.

    Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 2023; 69(2): 147-158 Nº de citas: 7 [doi:10.1165/rcmb.2022-0245OC]

  • Garcia-Diez, E; Lopez-Oliva, ME; Perez-Vizcaino, F; Perez-Jimenez, J; Ramos, S; Martin, MA.

    Dietary Supplementation with a Cocoa-Carob Blend Modulates Gut Microbiota and Prevents Intestinal Oxidative Stress and Barrier Dysfunction in Zucker Diabetic Rats

    Antioxidants. 2023; 12(8): Nº de citas: 5 [doi:10.3390/antiox12081519]

  • Olivencia, MA; Villegas-Esguevillas, M; Sancho, M; Barreira, B; Paternoster, E; Adao, R; Larriba, MJ; Cogolludo, A; Perez-Vizcaino, F.

    Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(15): Nº de citas: 4 [doi:10.3390/ijms241512350]

  • Olivencia, MA; Esposito, E; Brancaleone, V; Castaldo, S; Cirino, G; Perez-Vizcaino, F; Sorrentino, R; Bianca, RDD; Mitidieri, E.

    Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation

    PHARMACOLOGICAL RESEARCH. 2023; 194: Nº de citas: 8 [doi:10.1016/j.phrs.2023.106834]

  • Villegas-Esguevillas, M; Cho, SH; Vera-Zambrano, A; Kwon, JW; Barreira, B; Telli, G; Navarro-Dorado, J; Morales-Cano, D; de Olaiz, B; Moreno, L; Greenwood, I; Perez-Vizcaino, F; Kim, SJ; Climent, B; Cogolludo, A.

    The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    BIOMEDICINE & PHARMACOTHERAPY. 2023; 164: Nº de citas: 1 [doi:10.1016/j.biopha.2023.114952]

  • Willer, ASM; Santos-Gomes, J; Adao, R; Bras-Silva, C; Eyries, M; Perez-Vizcaino, F; Capuano, V; Montani, D; Antigny, F.

    Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart

    JOURNAL OF PHYSIOLOGY-LONDON. 2023; 601(17): 3717-3737 Nº de citas: 10 [doi:10.1113/JP284936]

  • Olivencia, MA; de Biedma-Elduayen, LG; Gimenez-Gomez, P; Barreira, B; Fernandez, A; Angulo, J; Colado, MI; O'Shea, E; Perez-Vizcaino, F.

    Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice

    BRITISH JOURNAL OF PHARMACOLOGY. 2023; 180(18): 2361-2376 Nº de citas: 6 [doi:10.1111/bph.16087]

  • Blanco, I; Marquina, M; Tura-Ceide, O; Ferrer, E; Ramirez, AM; Lopez-Meseguer, M; Callejo, M; Perez-Vizcaino, F; Peinado, VI; Barbera, JA.

    Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension

    Frontiers in Pharmacology. 2023; 14: Nº de citas: 3 [doi:10.3389/fphar.2023.1145994]

  • Morales-Cano, D; Izquierdo-Garcia, JL; Barreira, B; Esquivel-Ruiz, S; Callejo, M; Pandolfi, R; Villa-Valverde, P; Rodriguez, I; Cogolludo, A; Ruiz-Cabello, J; Perez-Vizcaino, F; Moreno, L.

    Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology. 2023; 14: Nº de citas: 6 [doi:10.3389/fphar.2023.1021535]

  • Vera-Zambrano, A; Baena-Nuevo, M; Rinne, S; Villegas-Esguevillas, M; Barreira, B; Telli, G; de Benito-Bueno, A; Blazquez, JA; Climent, B; Perez-Vizcaino, F; Valenzuela, C; Decher, N; Gonzalez, T; Cogolludo, A.

    Sigma-1 receptor modulation fine-tunes K(V)1.5 channels and impacts pulmonary vascular function

    PHARMACOLOGICAL RESEARCH. 2023; 189: Nº de citas: 4 [doi:10.1016/j.phrs.2023.106684]